Journal of Biomedical Advancement Scientific Research

Open Access • Peer Reviewed • Bi-Monthly

Outbreak Investigation of Manganese Toxicity Among Workers in a Selected Manganese Smelting Plant in Serenje District, Central Province, Zambia, 2022

Authors: Nangoma Haambote, Banda Dabwitso, Nyambe Sinyange, Shadreck Mufwaya and Isaac Banda
Published: 2026-03-12
Pages: 1-9
DOI: 10.63721/26JBASR0146
View PDFDOI Link

Abstract

Introduction: In September 2022, the Serenje district health office reported cases of lower limb weakness, dif f iculty walking, and impaired sexual function among workers at a manganese smelting plant. To investigate, we conducted a case-control study.

Methods: Cases were identified as individuals with confirmed neurological symptoms, elevated blood man ganese levels, and neurologist-validated brain imaging reports. The study included 20 cases and 42 controls, selected at random but balanced for their duration of employment.

Results: Symptoms among cases included difficulty walking (90%), joint pain (90%), impaired sexual func tion (90%) and difficulty talking (75%). Blood manganese levels among cases were exceptionally elevated, exceeding 20 times the normal range (0.116 to 0.623 ppm), compared to the reference range (0.005-0.02 ppm). Each additional day of overtime worked per week was associated with a 2.40-fold increased risk (95% CI = 1.05-6.35) of developing manganese toxicity. Notably, individuals using respirators had a 93% lower risk of adverse outcomes compared to non-users (OR = 0.07, 95% CI 0.01-0.51).

Conclusion: Our study highlights the association between overtime work and manganese toxicity risk. To prevent future occurrences of heavy metal toxicity among industrial workers, we emphasize the need for en hanced monitoring, adherence to safety protocols, and vigilant toxic exposure surveillance.

Copyright & License

© 2026 The Author(s). Published by WM Journals.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Back to Current IssueArchive